VaccineDesigner: A Web-based Tool for Streamlined Epitope-based Vaccine Design
Trygoniaris, D. G.; Anna, K.; Paraskeva, A.; Dhusku, E.; Tzimagiorgis, G.; Yiangou, M.; Kotzamanidis, C.; Malousi, A.
Show abstract
BackgroundMulti-epitope vaccines have become the preferred strategy for protection against infectious diseases by integrating multiple MHC-restricted T-cell and B-cell epitopes that elicit both humoral and cellular immune responses against pathogens. Computational methods address various aspects independently, yet their orchestration is technically challenging as most bioinformatics tools are accessible through heterogeneous interfaces and lack interoperability features. The present work proposes a novel framework for rationalized multi-epitope vaccine design that streamlines end-to-end analyses through an integrated Web-based environment. ResultsVaccineDesigner is a comprehensive Web-based framework that streamlines the design of protective epitope-based vaccines by seamlessly integrating computational methods for B-cell, CTL, and HTL epitope prediction. VaccineDesigner incorporates single epitope prediction and evaluation as well as additional analyses, such as multi-epitope vaccine generation, estimation of population coverage, molecular mimicry, and proteasome cleavage. The functionalities are transparently integrated into a modular architecture, providing a single access point for rationalized, multi-epitope vaccine generation, time and cost-effectively. ConclusionsVaccineDesigner is a Web-based interface for developing multi-epitope vaccines. Given a protein sequence, VaccineDesigner identifies and evaluates candidate B-cell, CTL, and HTL epitopes and constructs a library of multi-epitope vaccines that combine strong immunogenic responses, safety, and broad population coverage. The source code is available under the academic license at: https://github.com/BiolApps/VaccineDesigner. VaccineDesigner is freely accessible at: http://bioinformatics.med.auth.gr/VaccineDesigner.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning 94%
- CD8+ T cell cross-reactivity against SARS-CoV-2 conferred by other coronavirus strains and influenza virus 93%
- TCRex: detection of enriched T cell epitope specificity in full T cell receptor sequence repertoires 92%
Similar papers in this journal
- DeepImmuno: Deep learning-empowered prediction and generation of immunogenic peptides for T cell immunity 93%
- Design of an Epitope-Based Peptide Vaccine against the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): A Vaccine-informatics Approach 91%
- HLAncPred: A method for predicting promiscuous non-classical HLA binding sites 90%
Similar papers in this journal
- SARS-CoV-2 Omicron (BA.1 and BA.2) specific novel CD8+ and CD4+ T cell epitopes targeting spike protein. 95%
- Guiding a language-model based protein design method towards MHC Class-I immune-visibility profiles for vaccines and therapeutics 92%
- DoggifAI: a transformer based approach for antibodycaninisation 91%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.